Intelligent Generator of Research (IGoR)
National Institutes of Health · ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation ARPA-H-SOL-26-155 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
Amendment 01 adds Appendix E_Draft Model OT Agreement and provides revisions to Appendix B_Solution Summary Format and Instructions, as highlighted. --------------------------------------------------------------------------------------- ARPA-H intends to host a hybrid Proposers Day in early June in the Washington, D.C. metro area. Additional information will be posted when it becomes availiable. The Intelligent Generator of Research (IGoR) program aims to eliminate longstanding inefficiencies in research and accelerate the development of effective therapies for complex diseases by creating an … (show all)
AI-enabled interoperable research ecosystem. IGoR would develop: 1) mechanistic disease models that encode causal biological relationships across scales, 2) an AI orchestration layer that identifies knowledge gaps and designs optimal experiments, 3) a layered protocol architecture that enables any qualified laboratory to execute the same experiment reproducibly, and 4) a distributed marketplace of validated laboratories that execute standardized protocols and return gold-standard data. Together, these components form a cycle of hypothesis generation, experimentation, and model refinement that enables researchers to create validated knowledge at least 10x more rapidly than conventional approaches. Ultimately, IGoR will empower researchers at every level to pursue bold, unconventional research directions that are currently too slow, too complex, or too resource?intensive.
Who won similar work
58 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), same NAICS 541715.
Single-winner award sizes (38): middle half $2.6M to $23.2M, median $9.8M; range $10K to $79.3M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| DUKE UNIVERSITY Durham NC 27705 USA | 2 | $36.3M | Mar 31, 2025 |
| The TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 630 WEST 168TH STREET BOX 49 NEW YORK NY 10032 USA | 2 | $17.1M + 1 shared | Sep 25, 2026 |
| Northwestern University 750 N. LAKE SHORE DRIVE RUBLOFF 7TH FLOOR CHICAGO IL 60611 USA | 2 | $7.7M + 1 shared | Apr 10, 2025 |
| WAKE FOREST UNIVERSITY HEALTH SCIENCES MEDICAL CENTER BLVD. Winston Salem NC 27157 USA | 2 | $4.9M + 1 shared | Apr 10, 2025 |
| SCIOME LLC | 1 | $79.3M | Aug 27, 2026 |
| UNIVERSITY OF MISSISSIPPI MEDICAL CENTER Jackson MS 39216 USA | 1 | $63.9M | Sep 15, 2025 |
| TEMPUS AI, INC · $TEM · $1.4B | 1 | $60.6M | Sep 17, 2025 |
| WAKE FOREST UNIVERSITY HEALTH SCIENCES Winston Salem NC 27157 USA | 1 | $49.5M | Sep 15, 2025 |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL ADMINISTRATIVE OFFICE BUILDING, SUITE 2200 104 AIRPORT DRIVE, CB# 1350 Chapel Hill NC 27599 USA | 1 | $35.0M | Dec 6, 2024 |
| EMINENT SERVICES CORP | 1 | $32.9M | Mar 30, 2026 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- $TEM reported $1.4B revenue (12 months to Jun 30, 2026). The median single-winner award in these 38 past awards, $9.8M, is 0.7% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 7, 2026AMERICAN TYPE CULTURE COLLECTION Manassas VA 20110 USA$48.0M (shared ceiling)VACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESShared multiple-award ceiling, not one company's win (Materiality N/A)
- Oct 7, 2026ADVANCED BIOSCIENCE LABORATORIES, INC.$48.0M (shared ceiling)VACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESShared multiple-award ceiling, not one company's win (Materiality N/A)
- Oct 7, 2026SIA PARTNERS U.S., INC.$48.0M (shared ceiling)VACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESShared multiple-award ceiling, not one company's win (Materiality N/A)
- Oct 7, 2026FISHER BIOSERVICES INC$48.0M (shared ceiling)VACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESShared multiple-award ceiling, not one company's win (Materiality N/A)
- Oct 7, 2026BCG FEDERAL CORP.$48.0M (shared ceiling)VACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESShared multiple-award ceiling, not one company's win (Materiality N/A)
- Oct 7, 2026PPD DEVELOPMENT LP$48.0M (shared ceiling)VACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESShared multiple-award ceiling, not one company's win (Materiality N/A)
- Sep 28, 2026Versiti Blood Health, Inc.$7.4M (shared ceiling)A--Recipient Epidemiology and Donor Evaluation StudyShared multiple-award ceiling, not one company's win (Materiality N/A)
- Sep 28, 2026EMORY UNIVERSITY 1599 CLIFTON ROAD NE 4TH FLOOR MAILSTOP 1599-001-1BA Atlanta GA 30322 USA$7.4M (shared ceiling)A--Recipient Epidemiology and Donor Evaluation StudyShared multiple-award ceiling, not one company's win (Materiality N/A)
- Sep 25, 2026WESTAT, INC.$21.4MA--REDS-V-Data Coordinating CenterNo listed company matched (Materiality N/A)
- Sep 25, 2026VITALANT 9305 E VIA DE VENTURA Scottsdale AZ 85258 USA$7.4M (shared ceiling)A--The Recipient Epidemiology and Donor Evaluation StShared multiple-award ceiling, not one company's win (Materiality N/A)
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
- 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 21 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.